Wegovy 3-Week Results: What's Real and What's Too Early to Judge

The biggest myth about week three: that it should already be working 'properly'

A lot of people searching for three-week results are doing so because they expected something more dramatic by now, and they're wondering whether their treatment is faulty or whether they were sold a promise that won't hold. That frustration is completely understandable. The gap between what's described in clinical summaries and what you feel in week three is real, and it deserves a straight answer rather than hedging.

Here is what's actually happening: the 0.25 mg dose you're almost certainly still on was designed to let your body get used to a GLP-1 receptor agonist, not to produce the weight-loss effect. The significant results seen in the STEP 1 trial, published in the New England Journal of Medicine, built over 68 weeks, with participants spending months working up through 0.5 mg, 1.0 mg, and 1.7 mg before landing at 2.4 mg maintenance. Week three sits inside the adjustment window, not the treatment window. Expecting significant fat loss at this point is a bit like judging a flight by the taxiing stage.

The full Wegovy overview on this site explains the titration schedule in more detail if you want to understand how the dose progression works before your next clinical review.

What most people do (and don't) notice at the three-week mark

At week three on 0.25 mg, the most commonly reported experiences fall into two camps. Some people notice their appetite has quietened slightly: meals feel more filling, snacks feel less necessary, and the urge to eat past satiety starts to fade. This is the GLP-1 mechanism beginning to register, though at starter-dose levels it's rarely dramatic.

Others notice primarily the side effects: mild nausea after the injection, some looser stools, a general feeling of fullness that isn't entirely comfortable. This is normal, and on most people's timelines it eases within a few weeks. The NHS medicines information for semaglutide lists these gastrointestinal effects as the most common early responses, typically mild to moderate and settling as the body adjusts.

A smaller group notices almost nothing at three weeks. No appetite change, no side effects worth mentioning. That doesn't signal failure. At starter dose, some people's systems adapt quickly and quietly. The real signal will come as you move through the titration steps. If you're curious how the picture changes as the weeks accumulate, what people typically experience at six weeks gives you a useful next reference point.

What matters more than any single early reading is whether the dose increases are happening on schedule and whether your prescriber has a clear view of how you're responding. At a properly supervised service, that review is ongoing, not just a box ticked at sign-up.

When the numbers start to move, and what the clinical evidence actually shows

Meaningful, measurable weight loss on Wegovy tends to become visible from around weeks six to twelve for most people, and it continues building through the titration period. The landmark figure most often cited (approximately 15% average body-weight reduction) comes from STEP 1, and it reflects 68 weeks of treatment at the full maintenance dose, not the first month.

For context on the earlier timeline, it helps to look at what was building during that period: the eight-week point is often when people first see a consistent downward trend on the scale, though individual variation is wide. Some people lose a few kilograms in the first month; others stay roughly flat before the titration kicks in properly.

The three-week mark is, genuinely, too early to draw conclusions about your personal response to Wegovy. It is not too early to establish good habits alongside treatment: adequate protein at meals, consistent hydration, and some resistance activity all support the medicine's appetite effects and help protect muscle mass during weight loss. Those habits compound over months, which is when Wegovy's effects also compound. For a broader look at how the timeline unfolds from the beginning, this guide to how long Wegovy takes to work sets out the full picture from week one to maintenance.

On the question of cost alongside the clinical picture: understanding private weight-loss treatment in the UK means understanding that the price reflects clinical oversight throughout that titration journey, not just the initial consultation.

What to do with your three-week experience, practically

If you're at week three and feeling uncertain, the most useful thing is a clear-eyed conversation with whoever is supervising your treatment. A good clinical service is reachable after you've started, not just before. Dose-increase timing, managing early side effects, and deciding whether your response is on track are all conversations that belong with a prescriber, not a forum.

If you haven't yet started Wegovy and you're researching what the early weeks look like before committing, that's a smart approach. Week one and week two accounts help fill in the picture before the stage you're reading about here. You might also want to look at what four weeks in typically looks like, since that's when many people first feel they're turning a corner.

For people wondering about how to access Wegovy through a regulated UK pharmacy, this page covers the legitimate routes and what to check before handing over a prescription. These are prescription-only medicines; clinical assessment isn't a formality, it's what makes the process safe.

If you have specific questions about your situation, speaking to our prescribers through a free consultation is the right next step. Our clinical team reviews every case personally, and aftercare is available seven days a week.